Age at transplantation and outcome after autologous stem cell transplantation in elderly patients with multiple myeloma

BACKGROUND AND OBJECTIVE: The optimal treatment of patients with multiple myeloma (MM) is not well defined, in part because these patients are underrepresented in clinical studies. Autologous stem cell transplantation (auto-SCT) after high-dose melphalan chemotherapy can result in a prolonged respon...

Full description

Bibliographic Details
Main Authors: Jean El Cheikh, Elias Kfoury, Boris Calmels, Claude Lemarie, Anne-Marie Stoppa, Reda Bouabdallah, Diane Coso, Jean-Marc Schiano De Collela, Patrick Ladaique, Jean-Albert Gastaut, Mohamad Mohty, Christian Chabannon, Didier Blaise
Format: Article
Language:English
Published: Elsevier 2011-01-01
Series:Hematology/Oncology and Stem Cell Therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S1658387611500585